Preclinical News and Research

RSS
RXi receives SBIR grant to enable discovery and preclinical development of sd-rxRNAs

RXi receives SBIR grant to enable discovery and preclinical development of sd-rxRNAs

Contract Manufacturing Offering introduced to the biopharmaceutical market by Olympus Biotech

Contract Manufacturing Offering introduced to the biopharmaceutical market by Olympus Biotech

Krembil scientists develop lab study to accurately predict outcomes of stroke neuroprotectant

Krembil scientists develop lab study to accurately predict outcomes of stroke neuroprotectant

Synthetic hybrid molecules more effectively tackle chemo-resistant cancers

Synthetic hybrid molecules more effectively tackle chemo-resistant cancers

Experimental stem cell treatment improves vision in blind mice

Experimental stem cell treatment improves vision in blind mice

InterMune receives Health Canada approval for Esbriet to treat idiopathic pulmonary fibrosis

InterMune receives Health Canada approval for Esbriet to treat idiopathic pulmonary fibrosis

Active Biotech, Ipsen announce new data on biomarkers from tasquinimod Phase II study in CRPC

Active Biotech, Ipsen announce new data on biomarkers from tasquinimod Phase II study in CRPC

Drug combinations show promise against metastatic melanoma

Drug combinations show promise against metastatic melanoma

MicroDose completes third and final MDT-637 Phase 1 study on RSV infection

MicroDose completes third and final MDT-637 Phase 1 study on RSV infection

Inhibiting TRPV4 protects against diet-induced obesity, inflammation and insulin resistance

Inhibiting TRPV4 protects against diet-induced obesity, inflammation and insulin resistance

Amakem commences AMA0076 Phase 2a study in glaucoma and ocular hypertension

Amakem commences AMA0076 Phase 2a study in glaucoma and ocular hypertension

Sarawak Biodiversity Centre in Malaysia, OSU to develop and commercialize anticancer agent

Sarawak Biodiversity Centre in Malaysia, OSU to develop and commercialize anticancer agent

Chronic respiratory disease treatments: an interview with Dr Sven Jan-Anders Karlsson, CEO of Verona Pharma

Chronic respiratory disease treatments: an interview with Dr Sven Jan-Anders Karlsson, CEO of Verona Pharma

NanoBio to present data from preclinical studies at 8th Annual International RSV Symposium

NanoBio to present data from preclinical studies at 8th Annual International RSV Symposium

New clinical trial to evaluate DEX-M74 against hereditary inclusion body myopathy

New clinical trial to evaluate DEX-M74 against hereditary inclusion body myopathy

Wiley announces publication of 6-volume Encyclopedia of Drug Metabolism and Interactions

Wiley announces publication of 6-volume Encyclopedia of Drug Metabolism and Interactions

Lonafarnib proves effective for children with progeria

Lonafarnib proves effective for children with progeria

pSivida reports revenues of $699,000 for fourth quarter 2012

pSivida reports revenues of $699,000 for fourth quarter 2012

Study reveals potential of NIR spectral imaging for intra-operative skin flap assessment

Study reveals potential of NIR spectral imaging for intra-operative skin flap assessment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.